{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:29Z","timestamp":1793723789453,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM113256"],"award-info":[{"award-number":["R01GM113256"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0255"],"award-info":[{"award-number":["W81XWH-19-1-0255"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2024,3,15]]},"DOI":"10.1038\/s41388-024-02951-3","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T09:03:19Z","timestamp":1706691799000},"page":"851-865","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Blocking LBH expression causes replication stress and sensitizes triple-negative breast cancer cells to ATR inhibitor treatment"],"prefix":"10.1038","volume":"43","author":[{"given":"Koteswararao","family":"Garikapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Chi","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunhwa","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-7553","authenticated-orcid":false,"given":"Priyamvada","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2661-509X","authenticated-orcid":false,"given":"Karoline J.","family":"Briegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"key":"2951_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938\u201348.","journal-title":"N Engl J Med"},{"key":"2951_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/PPO.0b013e3181d24ff7","volume":"16","author":"SJ Isakoff","year":"2010","unstructured":"Isakoff SJ. Triple-negative breast cancer: role of specific chemotherapy agents. Cancer J. 2010;16:53\u201361.","journal-title":"Cancer J"},{"key":"2951_CR3","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429\u201334.","journal-title":"Clin Cancer Res"},{"key":"2951_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10549-008-0295-8","volume":"118","author":"S Nofech-Mozes","year":"2009","unstructured":"Nofech-Mozes S, Trudeau M, Kahn HK, Dent R, Rawlinson E, Sun P, et al. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers. Breast Cancer Res Treat. 2009;118:131\u20137.","journal-title":"Breast Cancer Res Treat"},{"key":"2951_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas N.","year":"2012","unstructured":"Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370.","journal-title":"Nature"},{"key":"2951_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346\u201352.","journal-title":"Nature"},{"key":"2951_CR7","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-019-0582-4","volume":"25","author":"J Staaf","year":"2019","unstructured":"Staaf J, Glodzik D, Bosch A, Vallon-Christersson J, Reutersward C, Hakkinen J, et al. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. Nat Med. 2019;25:1526\u201333.","journal-title":"Nat Med"},{"key":"2951_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.molmed.2019.04.004","volume":"25","author":"PHG Duijf","year":"2019","unstructured":"Duijf PHG, Nanayakkara D, Nones K, Srihari S, Kalimutho M, Khanna KK. Mechanisms of genomic instability in breast cancer. Trends Mol Med. 2019;25:595\u2013611.","journal-title":"Trends Mol Med"},{"key":"2951_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"key":"2951_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/dbio.2001.0225","volume":"233","author":"KJ Briegel","year":"2001","unstructured":"Briegel KJ, Joyner AL. Identification and characterization of Lbh, a novel conserved nuclear protein expressed during early limb and heart development. Dev Biol. 2001;233:291\u2013304.","journal-title":"Dev Biol"},{"key":"2951_CR11","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bbrc.2009.12.032","volume":"391","author":"H Al-Ali","year":"2010","unstructured":"Al-Ali H, Rieger ME, Seldeen KL, Harris TK, Farooq A, Briegel KJ. Biophysical characterization reveals structural disorder in the developmental transcriptional regulator LBH. Biochem Biophys Res Commun. 2010;391:1104\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2951_CR12","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1128\/MCB.01418-09","volume":"30","author":"ME Rieger","year":"2010","unstructured":"Rieger ME, Sims AH, Coats ER, Clarke RB, Briegel KJ. The embryonic transcription cofactor LBH is a direct target of the Wnt signaling pathway in epithelial development and in aggressive basal subtype breast cancers. Mol Cell Biol. 2010;30:4267\u201379.","journal-title":"Mol Cell Biol"},{"key":"2951_CR13","first-page":"893","volume":"142","author":"LE Lindley","year":"2015","unstructured":"Lindley LE, Curtis KM, Sanchez-Mejias A, Rieger ME, Robbins DJ, Briegel KJ. The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage. Development. 2015;142:893\u2013904.","journal-title":"Development"},{"key":"2951_CR14","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1242\/dev.01887","volume":"132","author":"KJ Briegel","year":"2005","unstructured":"Briegel KJ, Baldwin HS, Epstein JA, Joyner AL. Congenital heart disease reminiscent of partial trisomy 2p syndrome in mice transgenic for the transcription factor Lbh. Development. 2005;132:3305\u201316.","journal-title":"Development"},{"key":"2951_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ydbio.2009.07.003","volume":"333","author":"KL Conen","year":"2009","unstructured":"Conen KL, Nishimori S, Provot S, Kronenberg HM. The transcriptional cofactor Lbh regulates angiogenesis and endochondral bone formation during fetal bone development. Dev Biol. 2009;333:348\u201358.","journal-title":"Dev Biol"},{"key":"2951_CR16","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1093\/molbev\/msu267","volume":"31","author":"KE Powder","year":"2014","unstructured":"Powder KE, Cousin H, McLinden GP, Craig Albertson R. A nonsynonymous mutation in the transcriptional regulator lbh is associated with cichlid craniofacial adaptation and neural crest cell development. Mol Biol Evol. 2014;31:3113\u201324.","journal-title":"Mol Biol Evol"},{"key":"2951_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ydbio.2020.10.014","volume":"470","author":"E Weir","year":"2021","unstructured":"Weir E, McLinden G, Alfandari D, Cousin H. Trim-Away mediated knock down uncovers a new function for Lbh during gastrulation of Xenopus laevis. Dev Biol. 2021;470:74\u201383.","journal-title":"Dev Biol"},{"key":"2951_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep07626","volume":"5","author":"Q Liu","year":"2015","unstructured":"Liu Q, Guan X, Lv J, Li X, Wang Y, Li L. Limb-bud and heart (LBH) functions as a tumor suppressor of nasopharyngeal carcinoma by inducing G1\/S cell cycle arrest. Sci Rep. 2015;5:7626.","journal-title":"Sci Rep"},{"key":"2951_CR19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/art.39060","volume":"67","author":"AK Ekwall","year":"2015","unstructured":"Ekwall AK, Whitaker JW, Hammaker D, Bugbee WD, Wang W, Firestein GS. The rheumatoid arthritis risk gene LBH regulates growth in fibroblast-like synoviocytes. Arthritis Rheumatol. 2015;67:1193\u2013202.","journal-title":"Arthritis Rheumatol"},{"key":"2951_CR20","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.4049\/jimmunol.1700719","volume":"199","author":"S Matsuda","year":"2017","unstructured":"Matsuda S, Hammaker D, Topolewski K, Briegel KJ, Boyle DL, Dowdy S, et al. Regulation of the cell cycle and inflammatory arthritis by the transcription cofactor LBH gene. J Immunol. 2017;199:2316\u201322.","journal-title":"J Immunol"},{"key":"2951_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ebiom.2019.09.037","volume":"48","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Zhou J, Zou D, Hou D, Zhang H, Zhao J, et al. Overexpression of Limb-Bud and Heart (LBH) promotes angiogenesis in human glioma via VEGFA-mediated ERK signalling under hypoxia. EBioMedicine. 2019;48:36\u201348.","journal-title":"EBioMedicine"},{"key":"2951_CR22","doi-asserted-by":"publisher","first-page":"jcs254458","DOI":"10.1242\/jcs.254458","volume":"134","author":"H Liu","year":"2021","unstructured":"Liu H, Giffen KP, Grati M, Morrill SW, Li Y, Liu X, et al. Transcription co-factor LBH is necessary for the survival of cochlear hair cells. J Cell Sci. 2021;134:jcs254458.","journal-title":"J Cell Sci"},{"key":"2951_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/OTT.S152953","volume":"11","author":"J Chen","year":"2018","unstructured":"Chen J, Huang C, Chen K, Li S, Zhang X, Cheng J, et al. Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma. Onco Targets Ther. 2018;11:441\u20138.","journal-title":"Onco Targets Ther"},{"key":"2951_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000489801","volume":"47","author":"M Deng","year":"2018","unstructured":"Deng M, Yu R, Wang S, Zhang Y, Li Z, Song H, et al. Limb-bud and heart attenuates growth and invasion of human lung adenocarcinoma cells and predicts survival outcome. Cell Physiol Biochem. 2018;47:223\u201334.","journal-title":"Cell Physiol Biochem"},{"key":"2951_CR25","doi-asserted-by":"publisher","first-page":"e6885","DOI":"10.7717\/peerj.6885","volume":"7","author":"R Yu","year":"2019","unstructured":"Yu R, Li Z, Zhang C, Song H, Deng M, Sun L, et al. Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin\/FAK\/Akt pathway. PeerJ. 2019;7:e6885.","journal-title":"PeerJ"},{"key":"2951_CR26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41417-023-00633-y","volume":"30","author":"IC Young","year":"2023","unstructured":"Young IC, Brabletz T, Lindley LE, Abreu M, Nagathihalli N, Zaika A, et al. Multi-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways. Cancer Gene Ther. 2023;30:1234\u201348.","journal-title":"Cancer Gene Ther"},{"key":"2951_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bbrc.2018.11.155","volume":"508","author":"K Ashad-Bishop","year":"2019","unstructured":"Ashad-Bishop K, Garikapati K, Lindley LE, Jorda M, Briegel KJ. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice. Biochem Biophys Res Commun. 2019;508:536\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"2951_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/2211-5463.13325","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Luo Q, Xu Q, Xiong Y, Deng H. Limb-bud and heart development (LBH) contributes to glioma progression in vitro and in vivo. FEBS Open Bio. 2022;12:211\u201320.","journal-title":"FEBS Open Bio"},{"key":"2951_CR29","doi-asserted-by":"publisher","first-page":"e67811","DOI":"10.1371\/journal.pone.0067811","volume":"8","author":"R Lamb","year":"2013","unstructured":"Lamb R, Ablett MP, Spence K, Landberg G, Sims AH, Clarke RB. Wnt pathway activity in breast cancer sub-types and stem-like cells. PLoS One. 2013;8:e67811.","journal-title":"PLoS One"},{"key":"2951_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa063994","volume":"356","author":"R Liu","year":"2007","unstructured":"Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med. 2007;356:217\u201326.","journal-title":"N Engl J Med"},{"key":"2951_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2108","volume":"10","author":"G Honeth","year":"2008","unstructured":"Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K, et al. The CD44+\/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res. 2008;10:R53.","journal-title":"Breast Cancer Res"},{"key":"2951_CR32","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.2353\/ajpath.2010.091125","volume":"176","author":"AI Khramtsov","year":"2010","unstructured":"Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH. Wnt\/{beta}-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol. 2010;176:2911\u201320.","journal-title":"Am J Pathol"},{"key":"2951_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/jnci\/djn123","volume":"100","author":"X Li","year":"2008","unstructured":"Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008;100:672\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"2951_CR34","doi-asserted-by":"publisher","first-page":"13820","DOI":"10.1073\/pnas.0905718106","volume":"106","author":"CJ Creighton","year":"2009","unstructured":"Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA. 2009;106:13820\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2951_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.devcel.2012.06.018","volume":"23","author":"M Frontini","year":"2012","unstructured":"Frontini M, Kukalev A, Leo E, Ng YM, Cervantes M, Cheng CW, et al. The CDK subunit CKS2 counteracts CKS1 to control cyclin A\/CDK2 activity in maintaining replicative fidelity and neurodevelopment. Dev Cell. 2012;23:356\u201370.","journal-title":"Dev Cell"},{"key":"2951_CR36","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1002\/j.1460-2075.1992.tb05493.x","volume":"11","author":"Y Gu","year":"1992","unstructured":"Gu Y, Rosenblatt J, Morgan DO. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 1992;11:3995\u20134005.","journal-title":"EMBO J"},{"key":"2951_CR37","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1128\/MCB.18.11.6399","volume":"18","author":"G Mass","year":"1998","unstructured":"Mass G, Nethanel T, Kaufmann G. The middle subunit of replication protein A contacts growing RNA-DNA primers in replicating simian virus 40 chromosomes. Mol Cell Biol. 1998;18:6399\u2013407.","journal-title":"Mol Cell Biol"},{"key":"2951_CR38","doi-asserted-by":"publisher","first-page":"e21424","DOI":"10.1371\/journal.pone.0021424","volume":"6","author":"H Liaw","year":"2011","unstructured":"Liaw H, Lee D, Myung K. DNA-PK-dependent RPA2 hyperphosphorylation facilitates DNA repair and suppresses sister chromatid exchange. PLoS One. 2011;6:e21424.","journal-title":"PLoS One"},{"key":"2951_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.dnarep.2014.04.008","volume":"21","author":"AK Ashley","year":"2014","unstructured":"Ashley AK, Shrivastav M, Nie J, Amerin C, Troksa K, Glanzer JG, et al. DNA-PK phosphorylation of RPA32 Ser4\/Ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe. DNA Repair (Amst). 2014;21:131\u20139.","journal-title":"DNA Repair (Amst)"},{"key":"2951_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.molcel.2017.05.001","volume":"66","author":"L Toledo","year":"2017","unstructured":"Toledo L, Neelsen KJ, Lukas J. Replication catastrophe: when a checkpoint fails because of exhaustion. Mol Cell. 2017;66:735\u201349.","journal-title":"Mol Cell"},{"key":"2951_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman MK, Cimprich KA. Causes and consequences of replication stress. Nat Cell Biol. 2014;16:2\u20139.","journal-title":"Nat Cell Biol"},{"key":"2951_CR42","doi-asserted-by":"publisher","first-page":"a012716","DOI":"10.1101\/cshperspect.a012716","volume":"5","author":"A Marechal","year":"2013","unstructured":"Marechal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol. 2013;5:a012716.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2951_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","volume":"108","author":"J Smith","year":"2010","unstructured":"Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010;108:73\u2013112.","journal-title":"Adv Cancer Res"},{"key":"2951_CR44","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1126\/science.1083430","volume":"300","author":"L Zou","year":"2003","unstructured":"Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 2003;300:1542\u20138.","journal-title":"Science"},{"key":"2951_CR45","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41568-018-0034-3","volume":"18","author":"E Lecona","year":"2018","unstructured":"Lecona E, Fernandez-Capetillo O. Targeting ATR in cancer. Nat Rev Cancer. 2018;18:586\u201395.","journal-title":"Nat Rev Cancer"},{"key":"2951_CR46","doi-asserted-by":"publisher","first-page":"e005041","DOI":"10.1136\/jitc-2022-005041","volume":"10","author":"M Kwon","year":"2022","unstructured":"Kwon M, Kim G, Kim R, Kim KT, Kim ST, Smith S, et al. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer. J Immunother Cancer. 2022;10:e005041.","journal-title":"J Immunother Cancer"},{"key":"2951_CR47","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1136\/ijgc-2020-001694","volume":"30","author":"M McMullen","year":"2020","unstructured":"McMullen M, Karakasis K, Loembe B, Dean E, Parr G, Oza AM. DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment. Int J Gynecol Cancer. 2020;30:1824\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"2951_CR48","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science. 2017;355:1152\u20138.","journal-title":"Science"},{"key":"2951_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9:176\u201398.","journal-title":"Cancer Discov"},{"key":"2951_CR50","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","volume":"20","author":"JC Marine","year":"2020","unstructured":"Marine JC, Dawson SJ, Dawson MA. Non-genetic mechanisms of therapeutic resistance in cancer. Nat Rev Cancer. 2020;20:743\u201356.","journal-title":"Nat Rev Cancer"},{"key":"2951_CR51","doi-asserted-by":"publisher","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann BD, Jovanovic B, Chen X, Estrada MV, Johnson KN, Shyr Y, et al. Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS One. 2016;11:e0157368.","journal-title":"PLoS One"},{"key":"2951_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005;115:44\u201355.","journal-title":"J Clin Invest"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-02951-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-02951-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-02951-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T07:03:05Z","timestamp":1710486185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-02951-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,3,15]]}},"alternative-id":["2951"],"URL":"https:\/\/doi.org\/10.1038\/s41388-024-02951-3","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}